These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 19350116)

  • 1. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
    Sibbing D; Morath T; Stegherr J; Braun S; Vogt W; Hadamitzky M; Schömig A; Kastrati A; von Beckerath N
    Thromb Haemost; 2009 Apr; 101(4):714-9. PubMed ID: 19350116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clopidogrel and proton pump inhibitors: gastric protection at expense of vascular benefit?
    Serebruany V; Goto S
    Thromb Haemost; 2009 Apr; 101(4):607-9. PubMed ID: 19350100
    [No Abstract]   [Full Text] [Related]  

  • 3. Pantoprazole does not influence the antiplatelet effect of clopidogrel-a whole blood aggregometry study after coronary stenting.
    Neubauer H; Engelhardt A; Krüger JC; Lask S; Börgel J; Mügge A; Endres HG
    J Cardiovasc Pharmacol; 2010 Jul; 56(1):91-7. PubMed ID: 20410834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity.
    Harvey A; Modak A; Déry U; Roy M; Rinfret S; Bertrand OF; Larose É; Rodés-Cabau J; Barbeau G; Gleeton O; Nguyen CM; Proulx G; Noël B; Roy L; Paradis JM; De Larochellière R; Déry JP
    J Breath Res; 2016 Jan; 10(1):017104. PubMed ID: 26815196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of proton pump inhibitors on the antiplatelet potency of clopidogrel evaluated by 5 different platelet function tests.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):532-9. PubMed ID: 20729752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pantoprazole may enhance antiplatelet effect of enteric-coated aspirin in patients with acute coronary syndrome.
    Kasprzak M; Koziński M; Bielis L; Boinska J; Plazuk W; Marciniak A; Budzyński J; Siller-Matula J; Rość D; Kubica J
    Cardiol J; 2009; 16(6):535-44. PubMed ID: 19950090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention.
    Kwan J; Htun WW; Huang Y; Ko W; Kwan TW
    Vasc Health Risk Manag; 2011; 7():399-404. PubMed ID: 21796254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of PPIs and an H2 blocker on the antiplatelet function of clopidogrel in Japanese patients under dual antiplatelet therapy.
    Yamane K; Kato Y; Tazaki J; Tada T; Makiyama T; Imai M; Jinnai T; Ikeda T; Shirakawa R; Kimura T; Horiuchi H
    J Atheroscler Thromb; 2012; 19(6):559-69. PubMed ID: 22472213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study.
    Arbel Y; Birati EY; Finkelstein A; Halkin A; Kletzel H; Abramowitz Y; Berliner S; Deutsch V; Herz I; Keren G; Banai S
    Clin Cardiol; 2013 Jun; 36(6):342-6. PubMed ID: 23630016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction.
    Fontes-Carvalho R; Albuquerque A; Araújo C; Pimentel-Nunes P; Ribeiro VG
    Eur J Gastroenterol Hepatol; 2011 May; 23(5):396-404. PubMed ID: 21464720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of comedication with proton pump inhibitors (PPIs) on post-interventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy.
    Zuern CS; Geisler T; Lutilsky N; Winter S; Schwab M; Gawaz M
    Thromb Res; 2010 Feb; 125(2):e51-4. PubMed ID: 19781742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study.
    Cuisset T; Frere C; Quilici J; Poyet R; Gaborit B; Bali L; Brissy O; Morange PE; Alessi MC; Bonnet JL
    J Am Coll Cardiol; 2009 Sep; 54(13):1149-53. PubMed ID: 19761935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.
    Gilard M; Arnaud B; Cornily JC; Le Gal G; Lacut K; Le Calvez G; Mansourati J; Mottier D; Abgrall JF; Boschat J
    J Am Coll Cardiol; 2008 Jan; 51(3):256-60. PubMed ID: 18206732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel.
    Siller-Matula JM; Spiel AO; Lang IM; Kreiner G; Christ G; Jilma B
    Am Heart J; 2009 Jan; 157(1):148.e1-5. PubMed ID: 19081411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of different proton pump inhibitors on the antiplatelet activity of clopidogrel in combination with aspirin for patients undergoing coronary stent implantation].
    Cai J; Wu Q; Fan L; Liu CF; Wang ZG; Sun J
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2010 Aug; 26(3):266-9. PubMed ID: 21038666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.
    Hsiao FY; Mullins CD; Wen YW; Huang WF; Chen PF; Tsai YW
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1043-9. PubMed ID: 21823195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pantoprazole on dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary intervention.
    Mizia-Stec K; Haberka M; Mizia M; Lasota B; Kunecki M; Gieszczyk K; Chmiel A; Najda J; Kyrcz-Krzemień S; Gąsior Z
    Pharmacol Rep; 2012; 64(2):360-8. PubMed ID: 22661187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esomeprazole and rabeprazole did not reduce antiplatelet effects of aspirin/clopidogrel dual therapy in patients undergoing percutaneous coronary intervention: a prospective, randomized, case-control study.
    Liu LP; Wang Y; Si R; Yuan M; Cheng K; Guo WY
    Expert Opin Pharmacother; 2016; 17(1):7-16. PubMed ID: 26549402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G;
    Cardiovasc Ther; 2016 Aug; 34(4):209-15. PubMed ID: 27086085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of acute myocardial infarction in patients discharged on clopidogrel and a proton pump inhibitor after stent placement for acute myocardial infarction.
    Evanchan J; Donnally MR; Binkley P; Mazzaferri E
    Clin Cardiol; 2010 Mar; 33(3):168-71. PubMed ID: 20235209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.